Literature DB >> 8448846

Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation.

A H van Gennip1, S Busch, L Elzinga, A E Stroomer, A van Cruchten, E G Scholten, N G Abeling.   

Abstract

Recent findings suggest that inborn errors of pyrimidine catabolism are less rare than generally assumed. We propose a complete set of diagnostic methods for these disorders, suitable for the clinical chemistry laboratory, and present relevant reference data. Applications of thin-layer chromatography, high-performance liquid chromatography, and conventional cation-exchange amino acid analysis lead to detection of various defects in pyrimidine degradation, including the recently described deficiencies of dihydropyrimidine dehydrogenase and dihydropyrimidinase. We also illustrate the potential of the methods to analyze for the catabolites expected to be increased in the urine of patients with ureidopropionase deficiency. Possible pitfalls in the diagnosis and ways to prevent misdiagnosis are demonstrated. The methods offer possibilities for clinical chemistry laboratories to extend their diagnostic capacity to the new area of pyrimidine degradation defects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448846

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  16 in total

1.  Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation?

Authors:  B Assmann; G F Hoffmann; L Wagner; C Bräutigam; H W Seyberth; M Duran; A B Van Kuilenburg; R Wevers; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level.

Authors:  A B Van Kuilenburg; H Van Lenthe; B Assmann; G Göhlich-Ratmann; G F Hoffmann; C Bräutigam; R A Wevers; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

3.  Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.

Authors:  A B van Kuilenburg; P Vreken; L V Beex; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

4.  Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation.

Authors:  E Christensen; I Cezanne; S Kjaergaard; H Hørlyk; V Faurholt Pedersen; P Vreken; A B van Kuilenburg; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  1H NMR spectroscopy of body fluids in patients with inborn errors of purine and pyrimidine metabolism.

Authors:  R A Wevers; U Engelke; J J Rotteveel; A Heerschap; J G De Jong; N G Abeling; A H van Gennip; R A de Abreu
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

6.  Dihydropyrimidinase deficiency: confirmation of the enzyme defect in dihydropyrimidinuria.

Authors:  A H van Gennip; R A de Abreu; H van Lenthe; J Bakkeren; J Rotteveel; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

7.  Urinary uracil concentrations are a useful guide to genetic disorders associated with neurological deficits and abnormal pyrimidine metabolism.

Authors:  P M Davies; L D Fairbanks; J A Duley; H A Simmonds
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

8.  Inhibition of beta-ureidopropionase by propionate may contribute to the neurological complications in patients with propionic acidaemia.

Authors:  A H van Gennip; H van Lenthe; N G Abeling; E G Scholten; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 9.  When and how does one search for inborn errors of purine and pyrimidine metabolism?

Authors:  H A Simmonds
Journal:  Pharm World Sci       Date:  1994-04-15

Review 10.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.